As of 2024-07-27, the EV/EBITDA ratio of Cytosorbents Corp (CTSO) is -2.01. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CTSO's latest enterprise value is 51.76 mil USD. CTSO's TTM EBITDA according to its financial statements is -25.74 mil USD. Dividing these 2 quantities gives us the above CTSO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 22.9x | 21.4x |
| Forward P/E multiples | 20.7x - 22.6x | 22.0x |
| Fair Price | (9.73) - (10.65) | (10.21) |
| Upside | -1045.1% - -1133.5% | -1091.2% |
| Date | EV/EBITDA |
| 2024-07-26 | -2.01 |
| 2024-07-25 | -2.01 |
| 2024-07-24 | -1.97 |
| 2024-07-23 | -2.00 |
| 2024-07-22 | -2.05 |
| 2024-07-19 | -2.05 |
| 2024-07-18 | -2.03 |
| 2024-07-17 | -2.16 |
| 2024-07-16 | -2.20 |
| 2024-07-15 | -2.09 |
| 2024-07-12 | -2.12 |
| 2024-07-11 | -1.89 |
| 2024-07-10 | -1.93 |
| 2024-07-09 | -1.97 |
| 2024-07-08 | -1.97 |
| 2024-07-05 | -1.76 |
| 2024-07-03 | -1.65 |
| 2024-07-02 | -1.57 |
| 2024-07-01 | -1.31 |
| 2024-06-28 | -1.32 |
| 2024-06-27 | -1.47 |
| 2024-06-26 | -1.48 |
| 2024-06-25 | -1.46 |
| 2024-06-24 | -1.46 |
| 2024-06-21 | -1.53 |
| 2024-06-20 | -1.51 |
| 2024-06-18 | -1.43 |
| 2024-06-17 | -1.59 |
| 2024-06-14 | -1.61 |
| 2024-06-13 | -1.66 |
| 2024-06-12 | -1.65 |
| 2024-06-11 | -1.73 |
| 2024-06-10 | -1.72 |
| 2024-06-07 | -1.71 |
| 2024-06-06 | -1.71 |
| 2024-06-05 | -1.80 |
| 2024-06-04 | -1.71 |
| 2024-06-03 | -1.76 |
| 2024-05-31 | -1.74 |
| 2024-05-30 | -1.69 |
| 2024-05-29 | -1.74 |
| 2024-05-28 | -1.66 |
| 2024-05-24 | -1.74 |
| 2024-05-23 | -1.81 |
| 2024-05-22 | -1.82 |
| 2024-05-21 | -1.82 |
| 2024-05-20 | -1.90 |
| 2024-05-17 | -1.88 |
| 2024-05-16 | -1.67 |
| 2024-05-15 | -1.61 |